[1] |
WANG Hao, MA Jinfu, MA Rui, LI Xiaogang, ZHAO Qiang, ZHANG Xian.
One Case of Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium for Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 686-688.
|
[2] |
LIU Biqing, ZHANG Xiaotong, WANG Ke, XING Xiaoxuan, WANG Zhizhou, ZHUANG Wei, ZHANG Qingxia, ZHANG Lan, LI Xiaoling, DONG Xianzhe.
Adverse Drug Reaction in 385 Elderly Inpatients with Bacterial Pneumonia under Polypharmacy
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 206-210.
|
[3] |
LIU Qian, LI Bo, SHU Xinyang.
Lanqin oral liquid combined with antibacterial drugs for the treatment of acute tonsillitis: a systematic review and Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 916-920.
|
[4] |
HUANG Huanjun, MAI Jiaheng, ZHANG Yunhui, GUO Chenchen, LIANG Weiting.
Adverse drug reaction induced by antineoplastic drugs in a cancer hospital: an analysis of 613 cases
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 324-328.
|
[5] |
ZHU Yuanchao, ZHANG Yatong, HU Xin.
Principles and measures of medication risk management in the elderly
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1031-1034.
|
[6] |
HUANG Cuili, GAO Ao, WANG Jiaxi, GUO Haili, XU Xiaohan, CHENG Yinchu, GUO Daihong.
Automatic monitoring and assessment of antibiotics-related thrombocytopenia
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 807-811.
|
[7] |
ZHU Yuanchao, ZHAO Ming, HU Xin, SHI Hong.
Pharmacist-led practice in the management of elderly patients with polypharmacy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 817-821.
|
[8] |
ZHANG Qingxia, ZHOU Liujun, LI Xiaoling, WANG Yuqin.
Cefoperazone/sulbactam-related medication errors in the elderly and countermeasures
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 574-578.
|
[9] |
HUANG Shaolan, YANG Ge, LI Wei.
One case of muscle loss induced by ceftazidime-avibactam for injection combined with polymyxins B sulfate for injection after renal transplantation
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 583-584.
|
[10] |
ZHANG Yuan, HE Mei.
Pharmaceutical care for a case of Parkinson's syndrome caused by trimetazidine hydrochloride tablets in an elderly patient with renal insufficiency
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 343-345.
|
[11] |
WANG Yu, HUANG Jingyi, HOU Lixin, LI Shuang, CUI Yongkang, HUANG Lanwei.
Humoral immune characteristics of peripheral blood of CAP patients with antibiotic-associated DILI
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 132-135.
|
[12] |
LIU Hongliang, WANG Qing, HOU Yongfang.
Design and implementation of polypharmacy risk data management platform for common diseases of the elderly based on real world data
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1095-1098.
|
[13] |
CHU Yanqi, JIANG Yongxian, SHEN Jianghua, XING Xiaoxuan, ZHANG Qingxia, YAN Suying.
Analgesia-related risks after thoracoscopic surgery in elderly patients
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1023-1026.
|
[14] |
DONG Hanshuo, SUN Li, ZHAO Xiaoxiao, WANG Lianxin, YU Xiaokang, XIE Yanming.
Clinical characteristics and drug combination analysis of elemene injectable emulsion in the elderly in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 845-850.
|
[15] |
MA Bingbing, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian, LYU Jintao.
Consideration of rational use of traditional Chinese medicine and pharmaceutical services for the elderly based on literature analysis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 595-599.
|